{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Cognitive decline",
      "Late-life anxiety",
      "Medical comorbidity",
      "Tailored interventions"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32002946",
  "DateCompleted": {
    "Year": "2020",
    "Month": "02",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/978-981-32-9705-0_28"
    ],
    "Journal": {
      "ISSN": "0065-2598",
      "JournalIssue": {
        "Volume": "1191",
        "PubDate": {
          "Year": "2020"
        }
      },
      "Title": "Advances in experimental medicine and biology",
      "ISOAbbreviation": "Adv Exp Med Biol"
    },
    "ArticleTitle": "Anxiety Disorders in the Elderly.",
    "Pagination": {
      "StartPage": "561",
      "EndPage": "576",
      "MedlinePgn": "561-576"
    },
    "Abstract": {
      "AbstractText": [
        "Recent data has linked anxiety and its disorders in late life to increased morbidity and mortality, especially related to a higher cardiovascular burden and an increased cognitive decline. Clinically, anxiety symptoms may be more difficult to elicit in older adults who are less accurate in identifying anxiety symptoms and tend to minimize symptoms and to attribute symptoms to physical illness. Although SSRIs have proven more effective than psychotherapy in late-life anxiety, many elderly anxious subjects prefer psychotherapeutic interventions. These interventions appear to work best when tailored for the needs, expectations, and cultural background of older anxious subjects."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Western Psychiatric Institute and Clinic University of Pittsburgh, Pittsburgh, USA. andrcx@upmc.edu."
          }
        ],
        "LastName": "Andreescu",
        "ForeName": "Carmen",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Western Psychiatric Institute and Clinic University of Pittsburgh, Pittsburgh, USA."
          }
        ],
        "LastName": "Lee",
        "ForeName": "Soyoung",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Adv Exp Med Biol",
    "NlmUniqueID": "0121103",
    "ISSNLinking": "0065-2598"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Serotonin Uptake Inhibitors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "psychology",
        "therapy"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "psychology",
        "therapy"
      ],
      "DescriptorName": "Anxiety Disorders"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "Cardiovascular Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Comorbidity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychotherapy"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Selective Serotonin Reuptake Inhibitors"
    }
  ]
}